Select Agent (SA) Grams

2018 SA Grams

9/11/18 - New FAQs Regarding eFSAP Submission for APHIS/CDC Form 3

The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify eFSAP submissions related to reporting of a theft, loss, or release of a select agent or toxin.  The new FAQs (available here) are as follows:

  • Can my immediate notification be sent by email and then the APHIS/CDC Form 3 be submitted in eFSAP?
    The immediate notification can be sent via phone, email, or directly through eFSAP.  Complete APHIS/CDC Form 3 in eFSAP within 7 days of the incident. If initial notification is made using eFSAP (APHIS/CDC Form 3), then the date of your immediate notification will appear in APHIS/CDC Form 3 Section B within eFSAP.

  • How do I fill out an APHIS/CDC Form 3 Immediate Notification in eFSAP?
    Please see the Form 3 Immediate Notification Quick Reference Guide for detailed instructions.

  • How do I initiate an APHIS/CDC Form 3 but not officially submit it?
    When you start an APHIS/CDC Form 3, you can save it as a draft without clicking Submit.  Log into eFSAP and click on Form 3. Click Create Form 3. After you have started filling out the form, you can click Save at the bottom of the page to save the APHIS/CDC Form 3 as a draft without submitting it to FSAP for review.

  • Does the RO need to access the immediate submission to provide more detail or is a new APHIS/CDC Form 3 required?
    If the immediate notification was submitted by starting the APHIS/CDC Form 3, then complete the APHIS/CDC Form 3. If you sent an email or fax, you may upload the document as Supporting Documentation.

  • Will entities be required to maintain hard copy printouts of the APHIS/CDC Form 3 for reports of a theft, loss or release of a select agent or toxin documented in eFSAP?
    The electronic documentation in eFSAP acts as the record required by the select agent regulations. If there is not electronic documentation within eFSAP, it is the entity’s responsibility to ensure there is a record available.

  • Can an entity not currently registered with FSAP (non-registered entity or NRE) use eFSAP to submit an APHIS/CDC Form 3, Report of Theft, Loss or Release of a Select Agent or Toxin?
    At this time, an NRE must submit a report of theft, loss, or release of a select agent or toxin via email, fax, or mail.

If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

9/10/18 - New FAQs Posted on FSAP Website

The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify requirements related to the reporting of the identification of a select agent or toxin in a clinical or diagnostic or proficiency testing specimen as outlined in Sections 5, 6, and 9 of the select agent regulations. 

The following two new FAQs related to reporting can be found at https://www.selectagents.gov/faq-reporting.html:

  • What test or procedure determines whether a select agent or toxin is contained in a specimen presented for diagnosis or verification?

    The test or procedure used to determine whether a select agent or toxin is contained in a specimen presented for diagnosis or verification will depend on the select agent or toxin, and whether the agent is identified at the genus or the genus/species level.  A particular test or procedure used by an accredited laboratory, and/or disease program approved laboratory, and/or reference laboratory will have a recognized capability to make either a tentative or positive identification depending on the exactness of the identification needed.  In some cases an agent may need to be cultured for confirmatory test purposes and may also require specific disease program testing requirements.  The Federal Select Agent Program (FSAP) does not define which tests or procedures constitute positive identification of a select agent or toxin.

  • A registered public health laboratory frequently identifies Francisella tularensis and Yersinia pestis presented in diagnostic samples, but the laboratory is not registered for these agents.  After the agent is identified and an APHIS/CDC Form 4 is submitted, the registered entity destroys all materials within 7 days except for fixed slides that are located in an unregistered laboratory.  With regard to the select agents identified in this scenario, does the registered entity fall under the clinical diagnostic exemption found section 73.5 (destroy by recognize inactivation process) or is the entity subject to the inactivation requirements found in section 73.3 (validated inactivation procedure)?

    In order to exclude an agent (for which it is registered) from the requirement of the select agent and toxin regulations, a registered clinical or diagnostic laboratory is required to use an in-house validated inactivation procedure [following the requirements found in section 3(d)(4) or 4(d)(4)].  To exclude an agent for which it is not registered but has identified in a diagnostic or verification sample, a registered clinical or diagnostic laboratory is allowed to “destroy” the agent on-site by a recognized sterilization or inactivation process as outlined in section 5(a)(3) or 6(a)(3).

If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

 



  • 9/07/18 - Updated Inactivation Guidance Document Now Available

    The Federal Select Agent Program (FSAP) has revised its guidance document on inactivation, Guidance on the Inactivation or Removal of Select Agents and Toxins for Future Use, to explain how a principal investigator may sign documents electronically.

    The updated guidance is available on page 17 and states:

    For an individual to sign a document electronically, the entity should incorporate a method that:

    • Identifies and authenticates a person using at least two factors of authentication, including something the person knows (i.e., email password) and something the person has (e.g., a mobile phone with SMS text message access);
    • Provides a means to preserve the integrity of the signed record that is (a) portable, (b) independently verifiable, (c) tamper-evident, (d) granular, and (e) verifiable in the long-term; and
    • Meets the requirements of the Government Paperwork Elimination Act, the Electronic Signatures in Global and National Commerce Act (ESIGN, 15 U.S.C. ch. 96), and the Uniform Electronic Transactions Act. 

    In addition, the electronic form of signature must be executed or adopted by a person with the intent to sign the electronic record (e.g., to indicate a person’s approval of the information contained in the electronic record). Not only must this intent be captured at the time of each signature, but it must also be captured for each individual signature and be provided as granular evidence within the electronic signature system’s audit trail.  Each signed document must be backed by an audit trail that captures intent to sign for each individual signature and provides granular, consistent, time stamped evidence as to every step in the entire signature process. The electronic form of signature must be attached to or associated with the electronic record being signed, and each signature should be produced according to established standards. The signature should be independently verifiable, without relying on the electronic signature service or website to be validated.

    FSAP has also incorporated this information into a new frequently asked question posted on the website, now available at https://www.selectagents.gov/faq-ro.html.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 9/05/18 - Extensive Additional User Functionality for eFSAP Now Available (Including Data Table Redesigns, Histories, Email Notifications, and Inspection Module)

    The Federal Select Agent Program (FSAP) is pleased to announce the deployment of extensive additional functionality to the electronic Federal Select Agent Program (eFSAP) portal.

    Beginning September 5, 2018, authorized SAMS account holders at all registered entities will be able to experience the following system-wide enhancements and additional functionality within eFSAP:

    APHIS/CDC Form 1 Section 4, Section 7b, and Entity Amendment History Redesign

    APHIS/CDC Form 1 Section 4 and Section 7b data tables, as well as entity amendment histories, have been redesigned to provide an enhanced user experience:

    • Additional data columns have been added (e.g., Form 1 Section 4 status, Tier 1 status, SRA approved date, SRA expiration date, Form 1 Section 7b date added/withdrawn).
    • Data table columns now have fixed column headers during scrolling.
    • Data tables support filtering and sorting of each data column independently for rapid retrieval of pertinent information.

    Email Notifications Update

    Since March 2018, eFSAP has supported daily email notifications.  Unfortunately, entities have reported sporadic functionality of this feature.  With this release, our developers have reengineered the notification engine.  Once daily, Responsible Officials (ROs) and Alternate Responsible Officials (AROs) should receive an email notification if FSAP staff have performed any action generating a notification in an entity’s notification table.  The email will indicate that ROs and AROs should log into eFSAP at their earliest convenience to review the action. 

    Please continue to report to the eFSAP Help Desk if you believe entity email notifications are not functioning properly.

    Historical Strains (APHIS/CDC Form 1 Section 7b) and Historical Buildings/Rooms/Suites (Section 6)

    Starting with this release, any changes made to building/room/suite information in Form 1 Section 6 will be captured and displayed in the user interface as unique versions.  By selecting a history icon next to each building or room/suite, users will be able to view past information for that registered area.  

    In addition, select agent strains and select toxin serotypes that have been removed from an entity’s APHIS/CDC Form 1 Section 7b will be available in the user interface.  Users will be able to search past strains/serotypes by PI, date added, date withdrawn, etc.

    FSAP Inspection Module (Version One)

    FSAP is proud to bring to entities the first version of a new, interactive, electronic inspection module in eFSAP.  Over the next few months, FSAP will begin limited use of the inspection module during an initial pilot phase.  Features of the new eFSAP inspection module include the following:

    • Entities will have awareness regarding the inspection team and inspection focus as soon as FSAP staffs the inspection and generates checklists for the inspection.
    • As inspection findings are released for entity review, eFSAP generates automated entity notifications.
    • Entities have the ability to respond to inspection findings on an individual basis as time and resources permit.
    • Directly through the inspection module, FSAP has the ability to close inspection findings or ask for additional information.  Automated notifications are generated for these actions.
    • Entities have the ability to print their inspection findings with or without all correspondence with FSAP regarding the inspection findings.

    Available here is a tutorial with screenshots of the new inspection module features.  In addition, you may reach out to your FSAP point of contact for assistance with these new features.  If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system, please continue to contact our excellent eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 8/10/18 - Revision to FSAP Policy Statement: Validated Inactivation Procedure

    The Federal Select Agent Program (FSAP) has revised its policy on the application of the requirement for a “validated inactivation procedure” as used in the select agent regulations. This policy was originally published on April 6, 2017. The policy has been revised to clarify the requirements for an in-house validation procedure, as highlighted below:

    It is the policy of the FSAP that for purposes of the section 3(d)(4) and section 4(d)(4) exclusion provisions, the “validated inactivation procedure,” whose efficacy is confirmed by data generated from a viability testing protocol, must be performed in-house by the entity when the procedure will be used to inactivate a select agent or nucleic acids that can produce infectious forms of any select agent virus. In-house validation must be completed prior to the use of the procedure to render a select agent non-viable for future use or to render any nucleic acids that can produce infectious forms of any select agent virus non-infectious for future use.

    Please see the full policy for additional information. The policy is available here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 8/09/18 - Policy Statement & Guidance Document for Entity Annual Internal Inspections

    The Federal Select Agent Program (FSAP) has finalized a new policy statement and guidance document to assist entities in meeting the requirement regarding an annual internal inspection found in section 9(a)(6) of the select agent regulations (7 C.F.R. Part 331, 9 C.F.R. Part 121, and 42 C.F.R. Part 73).

    A draft version of the policy statement and guidance document was previously shared with the regulated community for review and input prior to being finalized.  The guidance document and policy statement do not reflect any major changes from the draft versions. 

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.

  • 8/06/18 - Final FSAP Policy Statement: Registration and Inspection of Effluent Decontamination Systems

    The Federal Select Agent Program (FSAP) has finalized its policy on the registration and inspection of Effluent Decontamination Systems (EDS).  The policy states that an area containing an EDS is not required to be listed on an entity’s registration under the conditions prescribed in the policy. 

    A draft version of the policy statement was previously shared with the regulated community for review and input prior to being finalized.  The final document does not reflect any major changes from the draft version.

    Please see the full policy for additional information. The policy is posted here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 8/03/18 - FSAP Policy Statement on Inactivation Certificate

    The Federal Select Agent Program (FSAP) has issued a revised inactivation policy that now addresses the requirements for a certificate used to document the inactivation of a select agent or material containing a select agent or regulated nucleic acids that can produce infectious forms of any select agent virus (“inactivated material”).  See, for example, 42 CFR § 73.17(a)(8). 

    The revised FSAP policy clarifies that the purpose of the signature of the Principal Investigator, or designee, on the certificate is to certify that the information listed on the certificate is true, complete, and accurate. 

    The revised FSAP policy also clarifies that the certificate must be signed by the appropriate Principal Investigator, or designee, before “inactivated material” is removed from registered space or the biocontainment level required for that material before inactivation. 

    Please see the full policy for additional information. The policy is posted here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 8/01/18 - New FAQs Regarding eFSAP Submission for APHIS/CDC Form 4

    The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify eFSAP submissions related to reporting the identification of a select agent or toxin in a clinical, diagnostic, or proficiency testing specimen as outlined in sections 5, 6, and 9 of the select agent regulations.  The new FAQs are as follows:

    • What are the fields that need to be completed for a Form 4 Immediate Notification?
      Log into eFSAP and click on Form 4. Click Create Form 4. For an immediate notification you must provide the following:
      • Select Agent or Toxin identified from the dropdown menu (Section B, Field 1)
      • Date of the identification (Section B, Field 2)
      • Whether any of the samples containing the select agent or toxin may have led to an unintentional release and/or exposure (Section B, Field 9)
      • Click Immediate Notification. You will need to fill out the complete Form 4 within 7 days of identifying a select agent or toxin. See the Form 4 Quick Reference Guides for more information.

    • Can I select more than one method of disposition in the APHIS/CDC Form 4?
      Yes. Select each method of disposition (Field 8) using the checkboxes as applicable to the situation.
      • Transferred – Indicate to whom the sample was sent and the date of the transfer.
      • Destroyed – Indicate method of destruction and date destroyed.
      • Retained – Indicate the Principal Investigator (PI) (from the dropdown menu of PIs approved to possess select agent and toxin).
      • Note: The “Retained” selection is not available for agents that you are not authorized by FSAP to possess.

    • Will entities be required to maintain hard copy printouts of the Form 4 for identifications of select agents or toxins documented in eFSAP?
      • The electronic documentation in eFSAP acts as the record required by the select agent regulations. If there is no electronic documentation within eFSAP, it is your responsibility to ensure a record is available for 3 years.

    • What are the deadlines regarding submitting an APHIS/CDC Form 4?
      • You must submit a completed APHIS/CDC Form 4A within 7 calendar days after identification of a select agent or toxin contained in a specimen presented for diagnosis or verification.

    • A sample provider not registered with FSAP submitted a diagnostic sample containing a suspected select agent to a reference laboratory for identification. How will the sample provider know whether to complete APHIS/CDC Form 4?
      • FSAP will send an email with a link to the APHIS/CDC Form 4 to the sample provider. Once the sample provider completes the information, they mail, fax, or email it back to FSAP.

    The FAQs can be found on the page titled Report of Identification of Select Agent or Toxin FAQs on the select agent website. 

    If you have any questions regarding this information, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 7/30/18 - Additional eFSAP Regional Training in Riverdale, MD: Register Now

    Over the last year, the Federal Select Agent Program (FSAP) has released extensive new functionality to the eFSAP system.

    FSAP shared information in recent SA Grams that as a part of its continued effort to provide eFSAP training and gain input from the regulated community, this summer, FSAP staff directly involved in eFSAP development are conducting a series of regional trainings.

    We have had such an overwhelming interest in our September date in the Washington D.C. area that the September 13, 2018 - Riverdale, MD training is full.  In order to accommodate all interested parties, FSAP is opening up registration for an additional training to be conducted in Riverdale the same week.  The new date and location will be as follows:

    • September 12, 2018 - Riverdale, MD. 4700 River Rd, Riverdale, Maryland 20737

    There is no need to attend both trainings as they are based in the same content.

    In addition, the following regional eFSAP trainings remain open for registration at this time:

    • July 31, 2018 – Madison, WI.  Madison Marriott West, 1313 John Q Hammons Dr, Middleton, WI 53562
    • August 30, 2018 – Austin, TX.  Austin Marriott South, 4415 S IH 35 Frontage Rd, Austin, TX 78744
    • September 18, 2018 – Hartford, CT. Hartford Marriott Farmington, 15 Farm Springs Rd, Farmington, CT 06032

    Persons interested in attending one or more of the remaining regional trainings can register for the events by visiting the registration webpage.  Registration will be limited to 50 attendees at each training. Training agendas and additional information will be provided to attendees approximately one week before the start date of each event.

    For awareness, these regional trainings are not limited to Responsible and Alternate Responsible Officials.  Anyone at your entity interested in receiving assistance with using eFSAP, previewing upcoming eFSAP features still currently in development, providing input on the current iteration of the system, and contributing ideas for desired functionality in future releases is more than welcome to attend.

    We encourage those who are able to attend one of these regional trainings. If you have any questions regarding this email, please contact the Federal Select Agent Program at 404-718-2000 or LRSAT@CDC.gov.


  • 7/12/18 - Additional eFSAP Regional Workshops: Register Now

    Over the last year, the Federal Select Agent Program (FSAP) has released extensive new functionality to the eFSAP system. 

    FSAP shared information in a July 25, 2018 SA Gram that as a part of its continued effort to provide eFSAP training and gain input from the regulated community, this summer, FSAP staff directly involved in eFSAP development will conduct a series of regional workshops. 

    Earlier this week, FSAP completed its first eFSAP regional workshop in Irvine, California. Many thanks to all of the Responsible and Alternate Responsible Officials who drove and flew in to make the workshop a success. Workshop attendees were able to preview upcoming eFSAP features still currently in development, provide valuable input on the current iteration of the system, and contribute ideas for desired functionality in future releases. The eFSAP development team was also able to answer questions and resolve issues that some workshop attendees were currently experiencing with the system.

    The following additional regional eFSAP workshops are now open for registration:

    • July 31, 2018 - Madison, WI.  Madison Marriott West, 1313 John Q Hammons Dr, Middleton, WI 53562
    • August 30, 2018 - Austin, TX.  Austin Marriott South, 4415 S IH 35 Frontage Rd, Austin, TX 78744
    • September 13, 2018 - Riverdale, MD.  4700 River Rd, Riverdale, Maryland 20737
    • September 18, 2018 - Hartford, CT. Hartford Marriott Farmington, 15 Farm Springs Rd, Farmington, CT 06032

    Entity representatives interested in attending one or more of these additional regional workshops can register for the events by visiting the registration webpage. Registration will be limited to 50 attendees at each workshop.  Workshop agendas and additional information will be provided to attendees approximately one week before the start date of each event.

    We encourage those who are able to attend one of these regional workshops. If you have any questions regarding this email, please contact the Federal Select Agent Program at 404-718-2000 or LRSAT@CDC.gov.


  • 7/10/18 - New eFSAP tools to assist users with APHIS/CDC Form 3

    The Federal Select Agent Program (FSAP) has developed two new reference guides to assist eFSAP users with the APHIS/CDC Form 3 features. The reference guides are to provide a quick reference on how to input data by each section into eFSAP regarding APHIS/CDC Form 3.

    The new quick reference guides are available online in the eFSAP Resource Center, and include the following materials:


    We hope that this information is helpful to you. If you have any questions related to the eFSAP system in general or with SAMS access to the system (e.g., log in problems, system outage) please contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.


  • 6/25/18 - Upcoming eFSAP Regional Workshops

    Over the last year, the Federal Select Agent Program (FSAP) has released extensive new functionality to the eFSAP system.

    As a part of our continued effort to provide eFSAP training and gain input from the regulated community, over the coming months, FSAP staff directly involved in eFSAP development will be conducting a series of regional workshops. These workshops will provide hands-on training and eFSAP assistance to attendees. There will also be time dedicated to gaining input from the regulated community on additional desired features and functionality. Further, FSAP will provide attendees with a preview of upcoming releases and answer any questions or concerns from the regulated community.

    The first workshop will be conducted on Monday July 9, 2018 in Irvine, California at the Anaheim Marriott Hotel, 700 West Convention Way, Anaheim, California 92802 from 9:00 – 3:00 pm Pacific Time. To register for the event, please visit the Training Registration Page.

    FSAP is planning to conduct additional one-day regional workshops in late July through September at the following locations: Austin, TX; Hartford, CT; Madison, WI; and Riverdale, MD. Specific dates and locations for these additional workshops will be communicated by SA Gram in the coming weeks.

    We encourage those who are able to attend one of these regional workshops. Registration will be limited to 50 attendees at each workshop.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 404-718-2000 or LRSAT@cdc.gov.


  • 6/15/18 - Exclusion of foot-and-mouth disease, FMD-LL3B3D A24 Cruzeiro, vaccine virus

    Based upon consultations with subject matter experts and a review of relevant published studies and information provided by the entities requesting the exclusions, the Federal Select Agent Program has determined that the FMD-LL3B3D A24 Cruzeiro, foot-and-mouth disease vaccine virus strain is excluded from the requirements of the select agent regulations because it does not pose a severe threat to animal health or animal products.

    Additional information regarding the specific excluded strain can be found at https://www.selectagents.gov/exclusions-usda.html.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.

  • 6/13/18 - Change in Leadership at the Agriculture Select Agent Services (AgSAS)

    The Federal Select Agent Program would like to announce a change in leadership at the Agriculture Select Agent Services (AgSAS). Effective May 30, Dr. Adis Dijab became the AgSAS National Director. To ensure program continuity, Drs. Dijab and Keith Wiggins (long-term Acting National Director for AgSAS) will coordinate the leadership transition through this month. By July 1, 2018, Dr. Dijab will assume full responsibility as the AgSAS National Director.

    Dr. Dijab received his Doctor of Veterinary Medicine degree from Zagreb University, College of Veterinary Medicine in Croatia. After eight years in a small animal clinic in Kentucky, Dr. Dijab began his career at the United States Department of Agriculture (USDA)’s Animal and Plant Health Inspection Service (APHIS) in 2004. Since then, he has served the USDA under both the USDA’s Food Safety Inspection Service and APHIS’ Veterinary Services, as a supervisory veterinary medical officer (VMO), field VMO, area veterinarian-in-charge, and program director. Dr. Dijab most recently served as the National Director of Animal Product Permitting and Negotiation Services with the National Import Export Services.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.

  • 5/30/18 - Publication of CDC’s 2017 DSAT Inspection Report Processing Annual Summary

    Today, CDC’s Division of Select Agents and Toxins (DSAT) published its third annual analysis of inspection report timeliness, the 2017 DSAT Inspection Report Processing Annual Summary

    Inspection reports play a critical role in ensuring the safety and security of work with select agents and toxins, and the data show that DSAT continues to make substantial improvements in its ability to provide timely feedback to entities.  Key findings include the following:

    • Nearly all inspection reports – 96 percent – issued by DSAT in 2017 were issued within DSAT’s target of 30 business days.  Only six reports out of 142 did not meet this goal. 
    • This reflects an improvement of 32 percent over 2016 data, even with an increase in the number of inspection reports issued, and a 50 percent improvement since 2015.
    • Once again, improvements in report timeliness occurred across all inspection types, with particularly notable improvements in maximum containment inspections.

    In addition, the analysis further examines the six delayed reports by looking closer at the timeframes and reasons for the delays.  Four of the six delayed reports were less than seven business days late; in all cases, administrative and/or workload reasons were the two reasons cited for delays.  For additional information, please see the full report (available here). 

    DSAT remains committed to meeting its 30-day target for issuing final inspection reports.  Overall, the substantial improvements in timeliness demonstrated in today’s report underscore DSAT’s continued commitment towards program improvement.  Today’s publication also reflects the program’s sustained pledge to increase transparency.

    If you have any questions about the report, please contact DSAT at 404-718-2000 or LRSAT@cdc.gov.

  • 5/21/18 - Increase in Reports of Release Involving Integrity of Positive Pressure Encapsulating Suits

    The Federal Select Agent Program (FSAP) has noticed an increase in reports of failures involving the integrity of the positive pressure encapsulating suits used in BSL-4 laboratories. A significant portion of these suit failures were identified during the exit chemical decontamination shower. As a result of these recent reports, we recommend entities maintaining BSL-4 laboratories consider the length of time a suit at the entity has been in service and conduct a more thorough examination of all suits, especially the seams and high wear areas, prior to entry into the BSL-4 laboratories.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 5/10/18 - New FAQ to Assist with Completing FD-961 Form

    The Federal Select Agent Program (FSAP) has posted a new Frequently Asked Question (FAQ) on its website in order to assist individuals with completing the FBI/Criminal Justice Information Services (CJIS) Division’s FD-961 form (Application for Security Risk Assessment). The new FAQ is as follows:

    When completing question #6 (Position) in Section II (Individual Information) on the FD-961 form, what position should be listed?

    Please select the one of the following roles that best describes the individual’s primary responsibilities:

    • Administrative
    • Alternate Responsible Official
    • Animal Care Staff
    • IT
    • Laboratorian
    • Janitorial
    • Maintenance
    • Owner/Controller
    • Principal Investigator
    • Responsible Official
    • Safety
    • Security
    • Shipping/Receiving
    • Other for individuals who do not fall under one of the roles noted above

    The FAQ can be found at: https://www.selectagents.gov/faq-risk.html.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 5/08/18 - New eFSAP tools to assist users with APHIS/CDC Forms 2 & 4

    The Federal Select Agent Program (FSAP) has developed a series of reference guides to assist eFSAP users with the APHIS/CDC Form 2 and APHIS/CDC Form 4 eFSAP features. The reference guides are to provide a quick reference on how to input data by each section into eFSAP regarding APHIS/CDC Form 2 and APHIS/CDC Form 4.

    The quick reference guides are available online in the eFSAP Resource Center, and include the following materials:


    We hope that this information is helpful to you. If you have any questions related to the eFSAP system in general or with SAMS access to the system (e.g., log in problems, system outage) please contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 5/08/18 - New FAQs Regarding Reporting Posted on FSAP Website

    The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify requirements related to the reporting of the identification of a select agent or toxin in a clinical or diagnostic or proficiency testing specimen as outlined in sections 5, 6, and 9 of the select agent regulations. The new FAQs are as follows:

    As part of a proficiency test, I identified a select toxin but in an amount below the excluded threshold amount listed in 42 CFR § 73. 3. Must I still report the identification using an APHIS/CDC Form 4?

    Yes, regardless of the amount identified, a registered entity or a clinical or diagnostic laboratory is required to report the identification of a select toxin contained in a sample presented for proficiency testing using APHIS/CDC Form 4.

    As part of a proficiency test, I identified an excluded attenuated strain of a select agent. Must I still report the identification on APHIS/CDC Form 4?

    No. Any excluded attenuated strain of a select agent or toxin is excluded from the requirements of select agent regulations, including the reporting requirements set forth in sections 5 and 6 of the regulations. The list of excluded select agent strains can be found at https://www.selectagents.gov/SelectAgentsandToxinsExclusions.html.

    If a diagnostic test only identifies a biological agent at the genus level, am I required to report the result if I only suspect that it is select agent?

    No. but should further testing confirm that the specimen contains a select agent, the continued possession of that select agent is only exempt from the select agent regulations if the laboratory does the following:

    • Unless directed otherwise by AgSAS or DSAT, within seven (7) calendar days after identification of the select agent or toxin, either transfer the select agent or toxin in accordance with Section 16 of the select agent regulations (requires prior approval by AgSAS or DSAT) or destroy the specimen on-site by a recognized sterilization or inactivation process.
    • Before transfer or destruction, secure the select agent or toxin to prevent theft, loss, or release.
    • Immediately report the identification of specific select agents and toxins listed in the regulations (See immediate notification list).
    • Maintain copies of all APHIS/CDC Form 4A reports for a period of (3) three years.

    The FAQs can be found at: https://www.selectagents.gov/faq-reporting.html.

  • 5/07/18 - Additional user functionality for eFSAP: 1) data table redesigns, 2) file upload enhancements

    The Federal Select Agent Program (FSAP) is pleased to announce the deployment of additional functionality to the eFSAP system.

    Beginning May 7, 2018, authorized SAMS-account holders at all registered entities will be able to enjoy the following system-wide enhancements and additional functionality within eFSAP:

    System-wide data table redesign

    Data tables within eFSAP (e.g., amendment summary table, APHIS/CDC Form 2, 3, and 4 tables, document tables) have been completely redesigned to provide additional information and an enhanced user experience. Changes include:

    • Additional data columns have been added (e.g., APHIS/CDC Form 2 approval and expiration dates, APHIS/CDC Form 3 incident type).
    • Data table columns now have fixed column headers during scrolling.
    • Data tables support filtering and sorting of each data column independently for rapid retrieval of specific documents, amendments, and APHIS/CDC Forms 2, 3 and 4.

    File upload enhancements and additional functionality

    The file upload feature of eFSAP has been redesigned to aid in subsequent search and retrieval, organization and version control, and to provide transparency regarding the status of FSAP review.

    • eFSAP file upload now supports close to 700 different file types (e.g., .pdf, .doc, .rtf).
    • Entities are now able to add text descriptors and assign files to predefined categories during the upload process to aide in future file search and retrieval.
    • eFSAP now automatically generates unique versions of entity files with the same title to prevent overwrite and assist in keeping track of the most up-to-date copy of a file.
    • After file upload, entity users are able to see the status of FSAP review (e.g., not yet reviewed, under review by FSAP, review complete).

    Attached to this message is a tutorial with screenshots of the new features. In addition, you may reach out to your FSAP point of contact for assistance with these new features. If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system (e.g., log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

  • 5/01/18 - Reminder regarding submission of Security Risk Assessment documentation

    The Federal Select Agent Program (FSAP) wishes to remind the regulated community that FSAP will not accept any information related to the FD-961 form (Application for Security Risk Assessment). The FD-961 form and photos required by the FBI must be sent as a pdf directly to the FBI’s Criminal Justice Information Services (CJIS) Division at FD961@leo.gov. An FD-961 form and/or photos submitted through eFSAP, to FSAP directly, or to any email except FD961@leo.gov will be deleted.

    Additional information regarding the security risk assessment is found at https://www.fbi.gov/services/cjis/bioterrorism-security-risk-assessment-form.

    FSAP appreciates your assistance in ensuring that any documentation related to the FD-961 form and appeals to restricted person notifications are sent appropriately.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300, option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 4/30/18 - OMB-approved FD-961 form now available from CJIS

    This email is being sent on behalf of the Federal Bureau of Investigation, Criminal Justice Information Services Division (CJIS) to notify you that the newly revised OMB-approved FD-961 form [OMB No. 1110-0039 (Exp. 4-30-2021)] has been posted online and is now available for use. The FD-961 form and the instructions can be found on the FBI's website at www.fbi.gov (search FD-961).

    If you have any questions regarding the FD-961 form, please contact CJIS at 304-625-4900.

  • 4/30/18 - Upcoming eFSAP Training: Register Now!

    In the coming days, the Federal Select Agent Program (FSAP) will be releasing extensive new functionality to the eFSAP system. This update brings users the ability to categorize files during the upload process and track the review status of documents that have been uploaded for FSAP review. Users will also be able to maintain, view, and retrieve multiple versions of their documents that have been uploaded over time. In addition, the pending update brings a redesign of data tables throughout the system, giving users the ability to filter and sort each table column independently for rapid retrieval of information.

    We have scheduled upcoming online training opportunities to assist you with using the new features. Online training sessions will be held between May 7-18, 2018. We encourage you to attend one of these training sessions.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 404-718-2000 or LRSAT@CDC.gov.

  • 3/13/18 - New eFSAP guidance to assist with user log on

    The Federal Select Agent Program (FSAP) is committed to providing the regulated community with an optimal eFSAP system user experience. In order to address and help troubleshoot log on issues that have been reported by some users, FSAP developed a reference guide containing reported issues and solutions. The guide is attached to this email and can be found online in the eFSAP Resource Center. We hope that this information is helpful to you in case you should experience one of the identified issues.

    If you have any questions related to the eFSAP system in general or with SAMS access to the system (e.g.,log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 3/06/18 - Reminder of Assistance Provided by Federal Bureau of Investigation Field Office Weapons of Mass Destruction Coordinator

    The below reminder is being sent on behalf of the Federal Bureau of Investigation, Weapons of Mass Destruction (WMD) Coordinator.

    The local Federal Bureau of Investigation Field Office WMD Coordinator provides assistance for registered entities regarding security. They should be contacted for support and assessments when suspicious behavior and activities are encountered, including cybersecurity-related issues. Biosecurity awareness training and exercises to prevent, detect, deter, and respond to threats to facilities, personnel, and research/inventory are also available.

    To engage this service, you can contact your Federal Bureau of Investigation WMD Coordinator (contact information found at http://www.fbi.gov/contact-us/field), provide identification, and request to be connected to the WMD Coordinator.


  • 3/05/18 - Updated Incident Response Plan Guidance and Template Now Available

    The Federal Select Agent Program (FSAP) has updated its Incident Response Plan Guidance and the associated template to help entities in developing a site-specific incident response plan to ensure the security and safeguarding of select agents and toxins from natural and man-made disasters. The documents are now available here.

    Draft versions of this guidance document and template were previously shared with the regulated community for review and input prior to being finalized.  The final documents do not reflect any major changes from the draft versions.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 3/02/18 - Additional user functionality for eFSAP (APHIS/CDC Form 1 Section 5 amendments, email notifications, and view-only users)

    The Federal Select Agent Program (FSAP) is pleased to announce the deployment of additional functionality to the eFSAP system.

    APHIS/CDC Form 1 Section 5 Amendments:
    Beginning immediately, Responsible Officials (ROs) and Alternate Responsible Officials (AROs) have the ability to perform the following activities directly in eFSAP:

    • Modify Section 5A: Entity-Wide Security Assessment and Incident Response
    • Modify Section 5B: Entity-Wide Biosafety/Biocontainment
    • Modify Section 5C: Entry Requirements for Federal Select Agent Program Inspectors

    Email Notifications:
    eFSAP also now supports email notifications.  Once daily, ROs and AROs will receive an email if FSAP staff have executed any action that generated a notification in an entity’s notification table.  The email will indicate that ROs and AROs should log into eFSAP at their earliest convenience to review the action.

    View-only Users:
    eFSAP has been configured to accept a new class of “view-only” users that have access to the system in the following manner:

    • Users of this class have view-only access to their entity’s registration information and APHIS/CDC Forms 2 – 4
    • Users of this class are able to upload documents to the document repository on behalf of the entity
    • Users of this class are able to download documents from their entity’s eFSAP document repository

    ROs are requested to provide FSAP with a list of individuals that they would like to have this level of access for their entity. For each individual, please provide the following information:

    • Entity name
    • First name, last name, email address (single line per person)

    You may send the list using the text box on the eFSAP customer support desk online help form or through email at eFSAPSupport@cdc.gov.

    Attached to this message is a short tutorial with screenshots of the new features. In addition, FSAP has posted a training video to walk users through the submission of Section 5 amendments.  For your awareness, FSAP also recently posted online a new video showing how to modify strains and serotypes in eFSAP (APHIS/CDC Form 1 Section 7).

    You may contact your FSAP point of contact for assistance with these new features.  If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system (e.g.,log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form or through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/28/18 - Updated Avian Influenza Virus Guidance Now Available

    The Agricultural Select Agent Services (AgSAS) has updated the document Avian Influenza Viruses, which provides guidance for the regulation of Avian Influenza, including categorization, biocontainment, and the transfer of Highly Pathogenic and Low Pathogenic Avian Influenza viruses. The updated document is now available here.

    This version of the document includes revisions to AgSAS contact information, updated figures from the more recent mid-west Avian Influenza outbreak, and language reflecting the Policy Statement (issued on February 2, 2018) regarding the live bird lethality testing requirements for pathogenicity testing of reverse genetically derived Avian Influenza Viruses.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.

  • 2/14/18 - RO Workshop Presentations Now Available

    The Federal Select Agent Program (FSAP) recently posted presentations online from the November 28-30, 2017 in-person workshop for Responsible Officials held at the Animal and Plant Health Inspection Service headquarters in Riverdale, MD. The workshop provided participants with information about the new eFSAP information system portal, regulatory requirements for inactivation of select agents, and maintaining select agent regulatory compliance, as well as an opportunity to network with colleagues. The presentations are now available here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.

  • 2/14/18 - New FAQs on FSAP Website

    The Federal Select Agent Program (FSAP) has posted new Frequently Asked Questions (FAQs) on its website in order to clarify regulatory requirements in two areas:


    Please see the corresponding web links for more information.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/13/18 - FSAP policy statement on chemical inactivation of whole tissue or homogenized tissue

    The Federal Select Agent Program (FSAP) has issued a new policy regarding the chemical inactivation of whole tissue or homogenized tissue.

    In meeting the in-house validation/verification of inactivation by chemical inactivation of whole tissue or homogenized tissue, it is FSAP policy to allow entities to select one tissue type (either (1) the tissue that is expected to have the highest concentration of the specific agent to be inactivated or (2) determine agent concentration for the agent to be inactivated in a tissue before performing inactivation to use as the maximum limit for that agent) to serve as a surrogate for other tissues, including those in other animal models, so long as all standardized conditions are held constant such as the agent used, tissue size, and ratio of tissue to volume of inactivating chemical. A safety margin must be incorporated into the final chemical inactivation procedure to ensure the effective inactivation of the agent.

    Please see the full policy for additional information. The policy is posted here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/08/18 - AgSAS policy statement regarding biosafety level requirements for virulent Newcastle
    Disease virus

    The Agriculture Select Agent Services (AgSAS) has issued a policy statement regarding the biosafety level requirements for virulent Newcastle disease virus.

    It is the policy of the Agriculture Select Agent Services (AgSAS) that:

    • Any individual or entity conducting work with any non-exempted virulent Newcastle disease virus isolate must do so within an animal biosafety or biosafety level 3 (ABSL- or BSL-3) space, consistent with the Biosafety in Microbiological and Biomedical Laboratories recommendation for such agents.
    • An individual or entity may request a variance to this policy by submitting a request, accompanied by a risk assessment providing details of enhancements and preventative measures to mitigate work in a lower containment space, by email to AgSAS@aphis.usda.gov.

    The full policy is posted here.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.


  • 2/02/18 - AgSAS policy statement regarding live bird lethality testing requirements for
    pathogenicity testing of reverse genetically derived viruses for avian influenza virus

    The Agriculture Select Agent Services (AgSAS) has issued a final policy statement regarding the removal of live bird lethality testing requirements for determining the pathogenicity characteristics of reverse genetically derived viruses, for avian influenza viruses.

    It is the policy of the Agriculture Select Agent Services (AgSAS) that:

    • We will accept reassortant virus exclusion requests, absent of live bird lethality testing data, for avian influenza constructs that meet specific criteria related to replication, cleavage site alteration, and gene insert characterization.
    • In lieu of the bird lethality testing, AgSAS will require all reverse genetically derived H5/H7 viruses with PR8 or similar human vaccine strain backbone to confirm genetic sequencing and demonstrate LPAI virus functionality through alternate requirements specified in the policy statement.

    The full policy is posted here.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.


  • 2/05/18 - Update on Access Approval Expirations

    As the Federal Select Agent Program (FSAP) previously shared with the regulated community, the eFSAP system contains a feature to help Responsible Officials (ROs) monitor pending expiration of employee approval for access to select agents and toxins.  In the Section 4 screen of the APHIS/CDC Form 1 found in eFSAP, the system highlights when an individual’s access approval is about to expire.  To prevent an individual’s access to select agents and toxins from terminating unnecessarily, we recommend that any individual identified as needing a renewal (90 days from termination or “orange” designation) should immediately initiate the process for renewal by submitting a new form FD-961 to the Criminal Justice Information Services Division (CJIS).

    Should an individual’s access approval expiration date pass without having completed a renewal, FSAP will remove those individuals from the entity’s registration and their access to select agents and toxins will be revoked.  If this happens, the RO is responsible for requesting that the individual be added back to the registration.

    As previously shared, FSAP will no longer send out “expiring access approval” notification letters.  It is the responsibility of each RO to monitor the status of their entity’s individuals’ access approvals and ensure that the appropriate renewal paperwork is submitted in a timely manner.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 2/02/18 - Change in Leadership at the Agriculture Select Agent Services (AgSAS)

    The Federal Select Agent Program would like to announce a change in leadership at the Agriculture Select Agent Services (AgSAS). On Monday, February 5, 2018, Dr. Freeda Isaac will leave AgSAS to become the Executive Director of National Import Export Services, under Animal and Plant Health Inspection Service’s (APHIS) Veterinary Services.

    Also effective on February 5, Dr. Keith Wiggins will become AgSAS’ Acting National Director. Before this assignment, Dr. Wiggins served as the Associate National Director of AgSAS. Dr. Wiggins began his APHIS career in 2005. Throughout the last 13 years has served in leadership roles from enforcing regulations for the import of animal products and by-products to mitigate the introduction of foreign animal diseases, to ensuring that agricultural viruses, bacteria, and toxins are safeguarded to prevent agro-bioterrorism and public health threats. Prior to joining APHIS, Dr. Wiggins practiced veterinary medicine in North Carolina, was a Regional Veterinarian for Hill’s Pet Nutrition, and taught college courses at Livingstone College, the College of Southern Maryland, and Prince George’s Community College. Dr. Wiggins holds a Doctorate in Veterinary Medicine from Tuskegee University. He served as a Missile Launch Officer in the United States Air Force, and is currently serving as a Chief Public Health Officer in the New Jersey Air National Guard.

    If you have any questions regarding this email, please contact AgSAS at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov.


  • 1/25/18 - Marijuana Use by Individuals Approved for Access to Select Agents and Toxins

    It is has come to the attention of the Federal Select Agent Program (FSAP) that there may be some confusion within the regulated community concerning the use of marijuana by individuals approved for access to select agents and toxins in states where some use of marijuana is now legal as a matter of state law.    

    Responsible Officials need to clearly understand and communicate to persons within their entity, that any person who uses marijuana or holds a medical marijuana card, regardless of state law, is considered by the Federal Government to be an unlawful user of a controlled substance and is therefore a “restricted person” and prohibited by federal law from having access to select agents and toxins.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.

  • 1/17/18 - Exclusion of Burkholderia pseudomallei and Burkholderia malleistrains

    Based upon consultations with subject matter experts and a review of relevant published studies and information provided by the entities requesting the exclusions, the Federal Select Agent Program has determined that several attenuated strains of Burkholderia pseudomallei and Burkholderia mallei are not subject to the requirements of the select agent regulations.  These exclusions include:

    • Nine Burkholderia pseudomallei Δasd strains
    • Four Burkholderia mallei Δasd strains

    Additional information regarding the specific excluded strains can be found here.

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or AgSAS@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or lrsat@cdc.gov for CDC/DSAT entities.


  • 1/12/18 - Use of eFSAP for Immediate Notification Submissions (APHIS/CDC Forms 3 and 4A)

    The Federal Select Agent Program (FSAP) would like to ensure eFSAP users are aware that they can now submit immediate notifications for APHIS/CDC Form 3 and APHIS/CDC Form 4A directly to FSAP via the system.

    Attached to this message are tutorials with screenshots detailing these features.  (Available here).  

    eFSAP users may access the system at https://fsap.cdc.gov.  If you experience errors or have questions related to the eFSAP system in general or with SAMS access to the system (e.g.,log in problems, system outage) please continue to contact the eFSAP customer support desk using the online help form, through email at eFSAPSupport@cdc.gov, or by phone at (877) 232-3322.   You may also wish to visit our online eFSAP Resource Center

    If you have any questions regarding this email, please contact 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.


  • 1/09/18 - Additional eFSAP Training Videos Now Available

    The Federal Select Agent Program (FSAP) has recently posted several additional online videos to assist users with completing tasks in the electronic Federal Select Agent Program portal, eFSAP.

    The new videos, available here, will help users complete functions associated with APHIS/CDC Forms 1 – 4 and include the following:

    • How to change an entity’s name, abstract, or type (Form 1 Section 1 amendments)
    • How to change an entity’s physical or additional address (Form 1 Section 1 amendments)
    • How to add personnel to an entity’s registration (Form 1 Section 4 amendments)
    • How to submit an APHIS/CDC Form 2 Section 1
    • How to submit an APHIS/CDC Form 2 Section 2
    • How to submit an APHIS/CDC Form 2 Section 3
    • How to submit an APHIS/CDC Form 3
    • How to submit an APHIS/CDC Form 4a Sections a and b
    • How to submit an APHIS/CDC Form 4a Sections c and d
    • How to submit an APHIS/CDC Form 4b

    Additional resources will continue to be posted to this page as they become available.

    If you have any questions regarding this email, please contact the Federal Select Agent Program at 301-851-3300 option 3 (voice only) or agsas@aphis.usda.gov for APHIS/AgSAS entities, and 404-718-2000 or LRSAT@CDC.gov for CDC/DSAT entities.